Bupropion as a modulator of drug activity | Patent Number 11969421

US 11969421 B2
Application Number17841274
Publication NumberUS 20220313689 A1
Pendency1 year, 10 months, 20 days
Filled DateJun 15, 2022
Priority DateNov 5, 2013
Publication DateOct 6, 2022
Expiration DateNov 4, 2033
Inventor/ApplicantsHerriot Tabuteau
ExaminesHENLEY III, RAYMOND J
Art Unit1629
Technology Center1600
Assignments
Antecip Bioventures Ii Llc Axsome
Current
Antecip Bioventures Ii Llc AxsomeAxsome Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.